TP53 and melanoma: Because a significant subset of human NF1-mutant melanomas harbor genetic alterations leading to activation of the PI3K-AKT-mTOR pathway [2, 5], we hypothesized that targeting this pathway through inactivation of ptena/ptenb would drive melanomagenesis in nf1/p53-mutant zebrafish.